Vikram Thermo Fair Value
Vikram Thermo (VIKRAMTH) average fair value is ₹122.83 across 6 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹156.45 (-21.49%), fair value range ₹39.35–₹261.31. For live price and a broader fundamental view, visit VIKRAMTH stock live price.
Fair Value Analysis Export
VIKRAMTH Fair Value vs Current Price — Valuation Summary
VIKRAMTH average fair value, fair value range, price gap and valuation status across 6 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF). Explore Vikram Thermo intrinsic price to estimate fundamental worth using multiple valuation models.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
Discounted Cash Flow (DCF)
VIKRAMTH Fair Value Analysis — Data Sources & Coverage
Vikram Thermo financial data sources, valuation methods applied and sector benchmarks used. Analyse VIKRAMTH ownership pattern to track promoter, FII and institutional holdings.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
VIKRAMTH vs Chemicals Sector Peers — P/E, P/B & Market Cap
Vikram Thermo P/E ratio, P/B ratio and market capitalisation vs Chemicals sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Polychem | POLYCHEM | - | 1.8 | ₹86 |
| Kanchi Karpooram | KANCHI | 29.19 | 0.7 | ₹148 |
| Blue Pearl Agriventures | BPAGRI | 2564.0 | 25.33 | ₹1,622 |
| Omkar Pharmachem | OMKARPH | 157.39 | 3.03 | ₹29 |
| Beezaasan Explotech | BEEZAASAN | 20.83 | 1.94 | ₹309 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.